AnandRathi

Kabra Drugs Ltd Fundamental Analysis

Last Updated Date: 17 Sept 2026
19.22
+0.17 (+0.89%)

Kabra Drugs Ltd (Kabra Drugs) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹46 crore.

Kabra Drugs Ltd Overview

Market cap₹46 Crs
Volume64,188
Prev. Close₹19.05
Year range₹15.50 - ₹35.52
ISININE323K01017

Kabra Drugs Ltd Fundamentals

ROCE(TTM)19.05%
P/E Ratio (TTM)6.01
P/B Ratio1.54
Debt to Equity0.02
ROE16.75%
EPS (TTM)3.20
Dividend Yield0.00%
Book Value12.49
Profit Margin5.76%
Operating Margin6.48%

Kabra Drugs Ltd Historical Performance

1 Month Return-20.68%
6 Month Return-33.12%
3 Year Return500.62%
3 Month Return-24.42%
1 Year Return3.72%
5 Year Return255.93%

Kabra Drugs Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research